{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T12:53:41Z","timestamp":1688475221567},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Rheumatol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00393-021-01130-z","type":"journal-article","created":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T11:03:11Z","timestamp":1638356591000},"page":"225-235","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunglobulin-G4(IgG4)-assoziierte Erkrankungen"],"prefix":"10.1007","volume":"81","author":[{"given":"Thea","family":"Thiele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torsten","family":"Witte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,12,1]]},"reference":[{"issue":"6","key":"1130_CR1","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1056\/NEJMra1104650","volume":"366","author":"JH Stone","year":"2012","unstructured":"Stone\u00a0JH, Zen\u00a0Y, Deshpande\u00a0V (2012) IgG4-related disease. N\u00a0Engl J Med 366(6):539\u2013551. https:\/\/doi.org\/10.1056\/NEJMra1104650","journal-title":"N Engl J Med"},{"issue":"4","key":"1130_CR2","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.autrev.2004.10.005","volume":"4","author":"M Yamamoto","year":"2005","unstructured":"Yamamoto\u00a0M, Takahashi\u00a0H, Sugai\u00a0S, Imai\u00a0K (2005) Clinical and pathological characteristics of Mikulicz\u2019s disease (IgG4-related plasmacytic exocrinopathy). Autoimmun Rev 4(4):195\u2013200. https:\/\/doi.org\/10.1016\/j.autrev.2004.10.005","journal-title":"Autoimmun Rev"},{"issue":"3","key":"1130_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/cen.13238","volume":"86","author":"MN Stan","year":"2017","unstructured":"Stan\u00a0MN, Sonawane\u00a0V, Sebo\u00a0TJ, Thapa\u00a0P, Bahn\u00a0RS (2017) Riedel\u2019s thyroiditis association with IgG4-related disease. Clin Endocrinol (Oxf) 86(3):425\u2013430. https:\/\/doi.org\/10.1111\/cen.13238","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"9","key":"1130_CR4","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/modpathol.2012.72","volume":"25","author":"V Deshpande","year":"2012","unstructured":"Deshpande\u00a0V, Zen\u00a0Y, Chan\u00a0JKC et al (2012) Consensus statement on the pathology of IgG4-related disease. Mod Pathol 25(9):1181\u20131192. https:\/\/doi.org\/10.1038\/modpathol.2012.72","journal-title":"Mod Pathol"},{"issue":"9976","key":"1130_CR5","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/S0140-6736(14)60720-0","volume":"385","author":"T Kamisawa","year":"2015","unstructured":"Kamisawa\u00a0T, Zen\u00a0Y, Pillai\u00a0S, Stone\u00a0JH (2015) IgG4-related disease. Lancet 385(9976):1460\u20131471. https:\/\/doi.org\/10.1016\/S0140-6736(14)60720-0","journal-title":"Lancet"},{"key":"1130_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/358371","author":"K Uchida","year":"2012","unstructured":"Uchida\u00a0K, Masamune\u00a0A, Shimosegawa\u00a0T, Okazaki\u00a0K (2012) Prevalence of IgG4-related disease in Japan based on nationwide survey in 2009. Int J Rheumatol. https:\/\/doi.org\/10.1155\/2012\/358371","journal-title":"Int J Rheumatol"},{"key":"1130_CR7","doi-asserted-by":"publisher","first-page":"iii123","DOI":"10.1093\/rheumatology\/kez667","volume":"59","author":"F Maritati","year":"2020","unstructured":"Maritati\u00a0F, Peyronel\u00a0F, Vaglio\u00a0A (2020) IgG4-related disease: a clinical perspective. Rheumatology (Oxford) 59:iii123\u2013iii131. https:\/\/doi.org\/10.1093\/rheumatology\/kez667","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"1130_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1111\/j.1365-2222.2009.03207.x","volume":"39","author":"TC Smyrk","year":"2009","unstructured":"Smyrk\u00a0TC, Aalberse\u00a0RC, Stapel\u00a0SO, Schuurman\u00a0J, Rispens\u00a0T (2009) Immunoglobulin G4: an odd antibody. Curr Opin Rheumatol 39(1):74\u201379. https:\/\/doi.org\/10.1111\/j.1365-2222.2009.03207.x","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"1130_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/BOR.0000000000000558","volume":"31","author":"R Kamekura","year":"2019","unstructured":"Kamekura\u00a0R, Takahashi\u00a0H, Ichimiya\u00a0S (2019) New insights into IgG4-related disease: emerging new CD4+ T\u2011cell subsets. Curr Opin Rheumatol 31(1):9\u201315. https:\/\/doi.org\/10.1097\/BOR.0000000000000558","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"1130_CR10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s00117-016-0188-5","volume":"56","author":"T Witte","year":"2016","unstructured":"Witte\u00a0T (2016) Immunological principles of IgG4 related diseases. Radiologe 56(12):1043\u20131048. https:\/\/doi.org\/10.1007\/s00117-016-0188-5","journal-title":"Radiologe"},{"issue":"12","key":"1130_CR11","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1136\/jcp.2010.082958","volume":"63","author":"Y Sato","year":"2010","unstructured":"Sato\u00a0Y, Kojima\u00a0M, Takata\u00a0K et al (2010) Multicentric Castleman\u2019s disease with abundant IgG4-positive cells: a clinical and pathological analysis of six cases. J\u00a0Clin Pathol 63(12):1084\u20131089. https:\/\/doi.org\/10.1136\/jcp.2010.082958","journal-title":"J Clin Pathol"},{"issue":"1","key":"1130_CR12","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/BOR.0b013e3283413011","volume":"23","author":"JT Geyer","year":"2011","unstructured":"Geyer\u00a0JT, Deshpande\u00a0V (2011) IgG4-associated sialadenitis. Curr Opin Rheumatol 23(1):95\u2013101. https:\/\/doi.org\/10.1097\/BOR.0b013e3283413011","journal-title":"Curr Opin Rheumatol"},{"issue":"11","key":"1130_CR13","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1007\/s00106-019-00798-9","volume":"68","author":"M Jurkov","year":"2020","unstructured":"Jurkov\u00a0M, Olze\u00a0H, Klauschen\u00a0F, Bertelmann\u00a0E, Schneider\u00a0U, Arens\u00a0P (2020) IgG4-related orbitopathy as an important differential diagnosis of advanced silent sinus syndrome. HNO 68(11):864\u2013868. https:\/\/doi.org\/10.1007\/s00106-019-00798-9","journal-title":"HNO"},{"issue":"12","key":"1130_CR14","doi-asserted-by":"publisher","first-page":"2811","DOI":"10.1111\/J.1572-0241.2003.08758.X","volume":"98","author":"T Kamisawa","year":"2003","unstructured":"Kamisawa\u00a0T, Egawa\u00a0N, Nakajima\u00a0H (2003) Autoimmune pancreatitis is a\u00a0systemic autoimmune disease. Am J Gastroenterol 98(12):2811\u20132812. https:\/\/doi.org\/10.1111\/J.1572-0241.2003.08758.X","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"1130_CR15","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1097\/BOR.0b013e3283412f60","volume":"23","author":"K Takuma","year":"2011","unstructured":"Takuma\u00a0K, Kamisawa\u00a0T, Igarashi\u00a0Y (2011) Autoimmune pancreatitis and IgG4-related sclerosing cholangitis. Curr Opin Rheumatol 23(1):80\u201387. https:\/\/doi.org\/10.1097\/BOR.0b013e3283412f60","journal-title":"Curr Opin Rheumatol"},{"issue":"12","key":"1130_CR16","doi-asserted-by":"publisher","first-page":"1886","DOI":"10.1097\/PAS.0b013e3181bd535b","volume":"33","author":"Y Zen","year":"2009","unstructured":"Zen\u00a0Y, Inoue\u00a0D, Kitao\u00a0A et al (2009) IgG4-related lung and pleural disease: a clinicopathologic study of 21\u00a0cases. Am J Surg Pathol 33(12):1886\u20131893. https:\/\/doi.org\/10.1097\/PAS.0b013e3181bd535b","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"1130_CR17","first-page":"197","volume":"32","author":"RP Bensley","year":"2015","unstructured":"Bensley\u00a0RP, Schermerhorn\u00a0ML (2015) Inflammatory abdominal aortic aneurysm. Clin Scenar Vasc Surg Second Ed 32(2):197\u2013204","journal-title":"Clin Scenar Vasc Surg Second Ed"},{"issue":"10","key":"1130_CR18","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1038\/nrneph.2015.95","volume":"11","author":"FB Cortazar","year":"2015","unstructured":"Cortazar\u00a0FB, Stone\u00a0JH (2015) IgG4-related disease and the kidney. Nat Rev Nephrol 11(10):599\u2013609. https:\/\/doi.org\/10.1038\/nrneph.2015.95","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"1130_CR19","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1136\/annrheumdis-2013-204907","volume":"74","author":"MN Carruthers","year":"2015","unstructured":"Carruthers\u00a0MN, Khosroshahi\u00a0A, Augustin\u00a0T, Deshpande\u00a0V, Stone\u00a0JH (2015) The diagnostic utility of serum IgG4 concentrations in IgG4-related disease. Ann Rheum Dis 74(1):14\u201318. https:\/\/doi.org\/10.1136\/annrheumdis-2013-204907","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1130_CR20","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.semarthrit.2019.06.018","volume":"50","author":"J Tang","year":"2020","unstructured":"Tang\u00a0J, Cai\u00a0S, Ye\u00a0C, Dong\u00a0L (2020) Biomarkers in IgG4-related disease: a systematic review. Semin Arthritis Rheum 50(2):354\u2013359. https:\/\/doi.org\/10.1016\/j.semarthrit.2019.06.018","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"1130_CR21","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1002\/art.39205","volume":"67","author":"ZS Wallace","year":"2015","unstructured":"Wallace\u00a0ZS, Deshpande\u00a0V, Mattoo\u00a0H et al (2015) IgG4-related disease: clinical and laboratory features in one hundred twenty-five patients. Arthritis Rheumatol 67(9):2466\u20132475. https:\/\/doi.org\/10.1002\/art.39205","journal-title":"Arthritis. Rheumatol."},{"issue":"3","key":"1130_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10165-011-0532-6","volume":"22","author":"M Yamamoto","year":"2012","unstructured":"Yamamoto\u00a0M, Tabeya\u00a0T, Naishiro\u00a0Y et al (2012) Value of serum IgG4 in the diagnosis of IgG4-related disease and in differentiation from rheumatic diseases and other diseases. Mod Rheumatol 22(3):419\u2013425. https:\/\/doi.org\/10.1007\/s10165-011-0532-6","journal-title":"Mod Rheumatol"},{"issue":"3","key":"1130_CR23","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.humpath.2009.11.001","volume":"41","author":"M Takikita-Suzuki","year":"2010","unstructured":"Takikita-Suzuki\u00a0M, Ishida\u00a0M, Okabe\u00a0H (2010) Re-evaluation of IgG4 in systemic fibroinflammatory disease with intracardiac involvement. Hum Pathol 41(3):458\u2013459. https:\/\/doi.org\/10.1016\/j.humpath.2009.11.001","journal-title":"Hum Pathol"},{"issue":"1","key":"1130_CR24","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1136\/annrheumdis-2019-216561","volume":"79","author":"ZS Wallace","year":"2020","unstructured":"Wallace\u00a0ZS, Naden\u00a0RP, Chari\u00a0S et al (2020) The 2019 American college of rheumatology\/European league against rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis 79(1):77\u201387. https:\/\/doi.org\/10.1136\/annrheumdis-2019-216561","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"1130_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/acr.22058","volume":"66","author":"M Ebbo","year":"2014","unstructured":"Ebbo\u00a0M, Grados\u00a0A, Guedj\u00a0E et al (2014) Usefulness of 2\u2011[18F]-fluoro-2-deoxy-d-glucose-positron emission tomography\/computed tomography for staging and evaluation of treatment response in IgG4-related disease: a retrospective multicenter study. Arthritis Care Res 66(1):86\u201396. https:\/\/doi.org\/10.1002\/acr.22058","journal-title":"Arthritis Care Res"},{"issue":"2","key":"1130_CR26","doi-asserted-by":"publisher","first-page":"135","DOI":"10.3109\/03009742.2015.1055796","volume":"45","author":"C Campochiaro","year":"2016","unstructured":"Campochiaro\u00a0C, Ramirez\u00a0GA, Bozzolo\u00a0EP et al (2016) IgG4-related disease in Italy: clinical features and outcomes of a\u00a0large cohort of patients. Scand J Rheumatol 45(2):135\u2013145. https:\/\/doi.org\/10.3109\/03009742.2015.1055796","journal-title":"Scand J Rheumatol"},{"issue":"1","key":"1130_CR27","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s10165-011-0571-z","volume":"22","author":"H Umehara","year":"2012","unstructured":"Umehara\u00a0H, Okazaki\u00a0K, Masaki\u00a0Y et al (2012) Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 22(1):21\u201330. https:\/\/doi.org\/10.1007\/s10165-011-0571-z","journal-title":"Mod Rheumatol"},{"issue":"4","key":"1130_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0124233","volume":"10","author":"Y Su","year":"2015","unstructured":"Su\u00a0Y, Sun\u00a0W, Wang\u00a0C et al (2015) Detection of serum IgG4 levels in patients with igG4-related disease and other disorders. PLoS One 10(4):1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0124233","journal-title":"PLoS One"},{"issue":"1","key":"1130_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000492814","volume":"100","author":"J Backhus","year":"2019","unstructured":"Backhus\u00a0J, Seufferlein\u00a0T, Perkhofer\u00a0L, Hermann\u00a0PC, Kleger\u00a0A (2019) IgG4-related diseases in the gastrointestinal tract: clinical presentation, diagnosis and treatment challenges. Digestion 100(1):1\u201314. https:\/\/doi.org\/10.1159\/000492814","journal-title":"Digestion"},{"issue":"9","key":"1130_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0183844","volume":"12","author":"M Ebbo","year":"2017","unstructured":"Ebbo\u00a0M, Grados\u00a0A, Samson\u00a0M et al (2017) Long-term efficacy and safety of rituximab in IgG4-related disease: data from a\u00a0French nationwide study of thirty-three patients. PLoS One 12(9):1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0183844","journal-title":"PLoS One"},{"issue":"2","key":"1130_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0245601","volume":"16","author":"K Wang","year":"2021","unstructured":"Wang\u00a0K, Wang\u00a0Z, Zeng\u00a0Q et al (2021) Clinical characteristics of IgG4-related retroperitoneal fibrosis versus idiopathic retroperitoneal fibrosis. PLoS One 16(2):1\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0245601","journal-title":"PLoS One"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-01130-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00393-021-01130-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-021-01130-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T17:07:53Z","timestamp":1648660073000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00393-021-01130-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,1]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["1130"],"URL":"https:\/\/doi.org\/10.1007\/s00393-021-01130-z","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"value":"0340-1855","type":"print"},{"value":"1435-1250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,1]]},"assertion":[{"value":"3 November 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"<b>T.\u00a0Thiele<\/b>: A.\u00a0Finanzielle Interessen: Referentenhonorar oder Kostenerstattung als passiver Teilnehmer: DGRh Kongress 2021, Teilnahmegeb\u00fchren von HEXAL erhalten. \u2013\u00a0B.\u00a0Nichtfinanzielle Interessen: \u00c4rztin in Weiterbildung, Klinik f\u00fcr Rheumatologie und Immunologie der Medizinischen Hochschule Hannover seit 2018 | Mitgliedschaft: DGRh. <b>T.\u00a0Witte<\/b>: A.\u00a0Finanzielle Interessen: Honorar f\u00fcr Vortr\u00e4ge: Roche.\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Klinikdirektor, Klinik f\u00fcr Rheumatologie & Immunologie, Med. Hochschule Hannover | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Rheumatologie, Deutsche Gesellschaft f\u00fcr Immunologie.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf ExternalRef removed.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien. F\u00fcr Bildmaterial oder anderweitige Angaben innerhalb des Manuskripts, \u00fcber die Patienten zu identifizieren sind, liegt von ihnen und\/oder ihren gesetzlichen Vertretern eine schriftliche Einwilligung vor.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}